Rosemont, Ill. – July 17, 2025 — The Society for Vascular Surgery (SVS) acknowledges the increased public attention surrounding chronic venous insufficiency (CVI) following news reports of President Donald J.
Following extended negotiations in both the House and Senate, Congress narrowly passed a major reconciliation package, titled the One Big, Beautiful Bill Act (OBBBA), on July 3, which was signed into law by President Trump on July 4.
Rosemont, Ill. – The Society for Vascular Surgery (SVS) is pleased to announce the results of the 2025 elections for Vice President and Secretary, revealed today during the SVS Annual Business Meeting held as part of the Vascular Annual Meeting (VAM) in New Orleans, La.
Findings from a phase three, randomized controlled clinical trial demonstrate the superiority of Humacyte’s Acellular Tissue Engineered Vessel (ATEV) over autologous arteriovenous fistula (AVF) in high-risk patients with end-stage kidney disease (ESKD).
A large retrospective review of over 100,000 patients found the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in moderate peripheral artery disease (PAD) is associated with a decreased rate of cardiovascular events, major limb events, and inpatient admissions.
Findings from a comprehensive 20-year clinical study demonstrate treatment of functional popliteal artery entrapment syndrome (FPAES), particularly in combination with fasciotomy for exertional compartment syndrome, has shown highly effective outcomes, with 82% of patients returning to prior level of athletics.
Nearly 1,000 SVS members responded to an opinion poll (fielded in March/April) asking them to analyze key factors and assess whether a Federated Model for the Vascular Surgery Board (VSB) within the current American Board of Surgery (ABS) or a free-standing VSB outside of ABS, would best strength
Jim Craig, a longtime supporter and vascular advocate, will deliver the annual keynote address for the 2025 Vascular Annual Meeting (VAM25), held in New Orleans, June 4-7 at the Morial Convention Center.
According to a new national survey released by the Society for Vascular Surgery (SVS), primary care providers rank vascular disease among the top three health crises facing our aging population, only behind heart disease and cancer and ahead of obesity and diabetes.
The Vascular Surgery MVP Feedback from the CMS public comment period has been posted to the CMS website. The SVS is very grateful for all the feedback that was given. After reviewing the MVP candidates, the feedback for the Vascular Surgery MVP was consistent with other MVP candidates and issues previously identified by CMS.
"The Adventures of a Middle-Aged Woman in Vascular Surgery" might sound like the title of a personal memoir, but Dr. Britt H. Tonnessen, FACS, uses it as her introduction on social media to succinctly summarize her life.
The SVS is excited to announce that the Vascular Surgery MIPS Value Pathway (MVP) has been posted for public comment with CMS.
The Society for Vascular Surgery (SVS) and the Society for Vascular Nursing (SVN) join healthcare organizations nationwide in celebrating National Nurse Practitioner Week (Nov.
The American College of Surgeons (ACS) has elected Anton N. Sidawy, MD, MPH, FACS, DFSVS, MAMSE as president-elect of the ACS during their Annual Business Meeting on Oct. 22. He served as president of the Society for Vascular Surgery (SVS) in 2010.
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness
After a successful year, the Journal of Vascular Surgery (JVS) continues its internship program for senior integrated vascular residents and vascular fellows.
Carlos E. Pineda, MD, cirujano vascular certificado que ejerce en Seattle, Washington, reflexiona sobre su trayectoria de Guatemala a EE.
The Society for Vascular Surgery (SVS) Strategic Board of Directors (SBOD), at its January 2024 meeting, reached a consensus to form and launch a special task force appointed by immediate Past President Joseph Mills, MD, to assess the significant progress made by vascular surgery as a
Rosemont, Ill. – July 17, 2025 — The Society for Vascular Surgery (SVS) acknowledges the increased public attention surrounding chronic venous insufficiency (CVI) following news reports of President Donald J.
Following extended negotiations in both the House and Senate, Congress narrowly passed a major reconciliation package, titled the One Big, Beautiful Bill Act (OBBBA), on July 3, which was signed into law by President Trump on July 4.
Rosemont, Ill. – The Society for Vascular Surgery (SVS) is pleased to announce the results of the 2025 elections for Vice President and Secretary, revealed today during the SVS Annual Business Meeting held as part of the Vascular Annual Meeting (VAM) in New Orleans, La.
Findings from a phase three, randomized controlled clinical trial demonstrate the superiority of Humacyte’s Acellular Tissue Engineered Vessel (ATEV) over autologous arteriovenous fistula (AVF) in high-risk patients with end-stage kidney disease (ESKD).
A large retrospective review of over 100,000 patients found the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in moderate peripheral artery disease (PAD) is associated with a decreased rate of cardiovascular events, major limb events, and inpatient admissions.
Findings from a comprehensive 20-year clinical study demonstrate treatment of functional popliteal artery entrapment syndrome (FPAES), particularly in combination with fasciotomy for exertional compartment syndrome, has shown highly effective outcomes, with 82% of patients returning to prior level of athletics.
Nearly 1,000 SVS members responded to an opinion poll (fielded in March/April) asking them to analyze key factors and assess whether a Federated Model for the Vascular Surgery Board (VSB) within the current American Board of Surgery (ABS) or a free-standing VSB outside of ABS, would best strength
Jim Craig, a longtime supporter and vascular advocate, will deliver the annual keynote address for the 2025 Vascular Annual Meeting (VAM25), held in New Orleans, June 4-7 at the Morial Convention Center.
According to a new national survey released by the Society for Vascular Surgery (SVS), primary care providers rank vascular disease among the top three health crises facing our aging population, only behind heart disease and cancer and ahead of obesity and diabetes.
The Vascular Surgery MVP Feedback from the CMS public comment period has been posted to the CMS website. The SVS is very grateful for all the feedback that was given. After reviewing the MVP candidates, the feedback for the Vascular Surgery MVP was consistent with other MVP candidates and issues previously identified by CMS.
"The Adventures of a Middle-Aged Woman in Vascular Surgery" might sound like the title of a personal memoir, but Dr. Britt H. Tonnessen, FACS, uses it as her introduction on social media to succinctly summarize her life.
The SVS is excited to announce that the Vascular Surgery MIPS Value Pathway (MVP) has been posted for public comment with CMS.
The Society for Vascular Surgery (SVS) and the Society for Vascular Nursing (SVN) join healthcare organizations nationwide in celebrating National Nurse Practitioner Week (Nov.
Rosemont, Ill. – July 17, 2025 — The Society for Vascular Surgery (SVS) acknowledges the increased public attention surrounding chronic venous insufficiency (CVI) following news reports of President Donald J.
Following extended negotiations in both the House and Senate, Congress narrowly passed a major reconciliation package, titled the One Big, Beautiful Bill Act (OBBBA), on July 3, which was signed into law by President Trump on July 4.
Rosemont, Ill. – The Society for Vascular Surgery (SVS) is pleased to announce the results of the 2025 elections for Vice President and Secretary, revealed today during the SVS Annual Business Meeting held as part of the Vascular Annual Meeting (VAM) in New Orleans, La.
Findings from a phase three, randomized controlled clinical trial demonstrate the superiority of Humacyte’s Acellular Tissue Engineered Vessel (ATEV) over autologous arteriovenous fistula (AVF) in high-risk patients with end-stage kidney disease (ESKD).
A large retrospective review of over 100,000 patients found the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in moderate peripheral artery disease (PAD) is associated with a decreased rate of cardiovascular events, major limb events, and inpatient admissions.
Findings from a comprehensive 20-year clinical study demonstrate treatment of functional popliteal artery entrapment syndrome (FPAES), particularly in combination with fasciotomy for exertional compartment syndrome, has shown highly effective outcomes, with 82% of patients returning to prior level of athletics.
Nearly 1,000 SVS members responded to an opinion poll (fielded in March/April) asking them to analyze key factors and assess whether a Federated Model for the Vascular Surgery Board (VSB) within the current American Board of Surgery (ABS) or a free-standing VSB outside of ABS, would best strength
Jim Craig, a longtime supporter and vascular advocate, will deliver the annual keynote address for the 2025 Vascular Annual Meeting (VAM25), held in New Orleans, June 4-7 at the Morial Convention Center.
According to a new national survey released by the Society for Vascular Surgery (SVS), primary care providers rank vascular disease among the top three health crises facing our aging population, only behind heart disease and cancer and ahead of obesity and diabetes.
The Vascular Surgery MVP Feedback from the CMS public comment period has been posted to the CMS website. The SVS is very grateful for all the feedback that was given. After reviewing the MVP candidates, the feedback for the Vascular Surgery MVP was consistent with other MVP candidates and issues previously identified by CMS.
"The Adventures of a Middle-Aged Woman in Vascular Surgery" might sound like the title of a personal memoir, but Dr. Britt H. Tonnessen, FACS, uses it as her introduction on social media to succinctly summarize her life.
The SVS is excited to announce that the Vascular Surgery MIPS Value Pathway (MVP) has been posted for public comment with CMS.
The Society for Vascular Surgery (SVS) and the Society for Vascular Nursing (SVN) join healthcare organizations nationwide in celebrating National Nurse Practitioner Week (Nov.